ATOM vs REGN
Atomera Inc (ATOM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ATOM currently screens at market cap $341.1M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ATOM and REGN stock pages for the full models.
Not investment advice.